Clive Prestidge is Professor within University of South Australia (UniSA) Clinical and Health Science, a lead researcher in UniSA Cancer Research Institute and head of the Nanostructure and Drug Delivery research group. His research group works on engineering novel particle-based biomaterials with specific biological activity and their application to solve biopharmaceutical challenges, determining mechanisms for bioactivity through advanced biophysical analysis, and developing drug delivery solutions to address unmet clinical needs. More Info